Orally Disintegrating Tablet Excipient Market Size, Share, Growth, and Industry Analysis, By Type (Binders,Glidents,Diluents,Disintegrants,Others), By Application (Anti-Psychotics Drug,Anti-Epileptics Drug,Others), Regional Insights and Forecast to 2035
Detailed TOC of Global Orally Disintegrating Tablet Excipient Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
1 Study Coverage
1.1 Orally Disintegrating Tablet Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
2.1.1 Global Orally Disintegrating Tablet Excipient Revenue 2019-2030
2.1.2 Global Orally Disintegrating Tablet Excipient Sales 2019-2030
2.2 Orally Disintegrating Tablet Excipient Market Size by Region: 2023 Versus 2030
2.3 Orally Disintegrating Tablet Excipient Sales by Region (2019-2030)
2.3.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2019-2024
2.3.2 Global Orally Disintegrating Tablet Excipient Sales Forecast by Region (2025-2030)
2.3.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2019-2030)
2.4 Orally Disintegrating Tablet Excipient Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2019-2024
2.4.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2025-2030)
2.4.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2019-2030)
3 Global Orally Disintegrating Tablet Excipient by Manufacturers
3.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Sales
3.1.1 Global Orally Disintegrating Tablet Excipient Sales by Manufacturer (2019-2024)
3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue
3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2019-2024)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturer (2019-2024)
3.3 Global Orally Disintegrating Tablet Excipient Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Orally Disintegrating Tablet Excipient Manufacturers Covered: Ranking by Revenue
3.4.2 Global Orally Disintegrating Tablet Excipient Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Product Type
3.5.1 Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Orally Disintegrating Tablet Excipient Product Type
3.5.3 Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 BASF
4.1.1 BASF Company Information
4.1.2 BASF Description, Business Overview
4.1.3 BASF Orally Disintegrating Tablet Excipient Products Offered
4.1.4 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.1.5 BASF Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.1.6 BASF Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.1.7 BASF Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.1.8 BASF Recent Developments
4.2 JRS Pharma
4.2.1 JRS Pharma Company Information
4.2.2 JRS Pharma Description, Business Overview
4.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
4.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.2.5 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.2.6 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.2.7 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.2.8 JRS Pharma Recent Developments
4.3 Roquette
4.3.1 Roquette Company Information
4.3.2 Roquette Description, Business Overview
4.3.3 Roquette Orally Disintegrating Tablet Excipient Products Offered
4.3.4 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Roquette Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.3.6 Roquette Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.3.7 Roquette Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.3.8 Roquette Recent Developments
4.4 ABF Ingredients
4.4.1 ABF Ingredients Company Information
4.4.2 ABF Ingredients Description, Business Overview
4.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
4.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.4.5 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.4.6 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.4.7 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.4.8 ABF Ingredients Recent Developments
4.5 DFE Pharma
4.5.1 DFE Pharma Company Information
4.5.2 DFE Pharma Description, Business Overview
4.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
4.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.5.5 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.5.6 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.5.7 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.5.8 DFE Pharma Recent Developments
4.6 Evonik
4.6.1 Evonik Company Information
4.6.2 Evonik Description, Business Overview
4.6.3 Evonik Orally Disintegrating Tablet Excipient Products Offered
4.6.4 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Evonik Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.6.6 Evonik Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.6.7 Evonik Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.6.8 Evonik Recent Development
4.7 Merck KGaA
4.7.1 Merck KGaA Company Information
4.7.2 Merck KGaA Description, Business Overview
4.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
4.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.7.6 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.7.7 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.7.8 Merck KGaA Recent Development
4.8 Ashland
4.8.1 Ashland Company Information
4.8.2 Ashland Description, Business Overview
4.8.3 Ashland Orally Disintegrating Tablet Excipient Products Offered
4.8.4 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Ashland Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.8.6 Ashland Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.8.7 Ashland Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.8.8 Ashland Recent Development
4.9 Meggle Pharma
4.9.1 Meggle Pharma Company Information
4.9.2 Meggle Pharma Description, Business Overview
4.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
4.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.9.6 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.9.7 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.9.8 Meggle Pharma Recent Development
4.10 Shin-Etsu
4.10.1 Shin-Etsu Company Information
4.10.2 Shin-Etsu Description, Business Overview
4.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
4.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.10.6 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.10.7 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.10.8 Shin-Etsu Recent Development
4.11 Fuji Chemical Industries
4.11.1 Fuji Chemical Industries Company Information
4.11.2 Fuji Chemical Industries Description, Business Overview
4.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Products Offered
4.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.11.6 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.11.7 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.11.8 Fuji Chemical Industries Recent Development
4.12 McePharma (Vivesa holding)
4.12.1 McePharma (Vivesa holding) Company Information
4.12.2 McePharma (Vivesa holding) Description, Business Overview
4.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Products Offered
4.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.12.5 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.12.6 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.12.7 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.12.8 McePharma (Vivesa holding) Recent Development
4.13 Cargill Incorporated
4.13.1 Cargill Incorporated Company Information
4.13.2 Cargill Incorporated Description, Business Overview
4.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Products Offered
4.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.13.5 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.13.6 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.13.7 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.13.8 Cargill Incorporated Recent Development
4.14 Daicel Corporation
4.14.1 Daicel Corporation Company Information
4.14.2 Daicel Corporation Description, Business Overview
4.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Products Offered
4.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.14.5 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.14.6 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.14.7 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.14.8 Daicel Corporation Recent Development
4.15 Anhui Sunhere Pharmaceutical
4.15.1 Anhui Sunhere Pharmaceutical Company Information
4.15.2 Anhui Sunhere Pharmaceutical Description, Business Overview
4.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Products Offered
4.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
4.15.5 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Product in 2023
4.15.6 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Application in 2023
4.15.7 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2023
4.15.8 Anhui Sunhere Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2019-2030)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
5.1.2 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2025-2030)
5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2019-2030)
5.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2019-2030)
5.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2019-2024)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2025-2030)
5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2019-2030)
5.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2019-2030)
6.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
6.1.2 Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2025-2030)
6.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2019-2030)
6.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2019-2030)
6.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2019-2024)
6.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2025-2030)
6.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2019-2030)
6.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Orally Disintegrating Tablet Excipient Market Size YoY Growth 2019-2030
7.2 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
7.2.1 North America Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
7.2.2 North America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
7.3 North America Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
7.4 North America Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Region
8.2.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2019-2030)
8.2.2 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2019-2030)
8.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
8.4 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
9 Europe
9.1 Europe Orally Disintegrating Tablet Excipient Market Size YoY Growth 2019-2030
9.2 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
9.2.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
9.2.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
9.3 Europe Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
9.4 Europe Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Orally Disintegrating Tablet Excipient Market Size YoY Growth 2019-2030
10.2 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
10.2.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
10.2.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
10.3 Latin America Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
10.4 Latin America Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
11.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
11.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
11.3 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
11.4 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Orally Disintegrating Tablet Excipient Supply Chain Analysis
12.2 Orally Disintegrating Tablet Excipient Key Raw Materials and Upstream Suppliers
12.3 Orally Disintegrating Tablet Excipient Clients Analysis
12.4 Orally Disintegrating Tablet Excipient Sales Channel and Sales Model Analysis
12.4.1 Orally Disintegrating Tablet Excipient Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Orally Disintegrating Tablet Excipient Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Orally Disintegrating Tablet Excipient Distributors
13 Market Dynamics
13.1 Orally Disintegrating Tablet Excipient Industry Trends
13.2 Orally Disintegrating Tablet Excipient Market Drivers
13.3 Orally Disintegrating Tablet Excipient Market Challenges
13.4 Orally Disintegrating Tablet Excipient Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Our Clients